Changes in motor cortex excitability in facioscapulohumeral muscular dystrophy

Neuromuscular Disorders

Volumn 14, Issue 1, 2004, Pages 39-45

  Di Lazzaro, V ^a   Oliviero, A ^a   Tonali, P A ^a   Felicetti, L ^a   De Marco, M B P ^b   Saturno, E ^a   Pilato, F ^a   Pescatori, M ^a,d   Dileone, M ^a   Pasqualetti, P ^c,d   Ricci, E ^a,e  

^a CATHOLIC UNIVERSITY   (Italy)

^b IV Distretto ASL RM D ^*  (Italy)

^c FATEBENEFRATELLI HOSPITAL   (Italy)

^d IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^e Center for Neuromuscular Diseases   (Italy)

Author keywords

Cerebral cortex; Facioscapulohumeral muscular dystrophy; GABA; Intracortical inhibition; MEP; Transcranial magnetic brain stimulation

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; HUMAN; MOTOR CORTEX; MUSCLE DISEASE; NERVE CELL NETWORK; NERVE EXCITABILITY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REDUCTION; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 10744234006     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2003.08.002     Document Type: Article

References (44)

1. Upadhyaya M., Lunt P., Sarfarazi M., Broadhead W., Farnham J., Harper P.S. The mapping of chromosome 4q markers in relation to facioscapulohumeral muscular dystrophy (FSHD). Am J Hum Genet. 51:1992;404-410.
2. Wijmenga C., Hewitt J.E., Sandkuijl L.A., et al. Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat Genet. 2:1992;26-30.
3. Wijmenga C., Sandkuijl L.A., Moerer P., et al. Genetic linkage map of facioscapulohumeral muscular dystrophy and five polymorphic loci on chromosome 4q35-qter. Am J Hum Genet. 51:1992;411-415.
4. Sarfarazi M., Wijmenga C., Upadhyaya M., et al. Regional mapping of facioscapulohumeral muscular dystrophy gene on 4q35: combined analysis of an international consortium. Am J Hum Genet. 51:1992;396-403.
5. Hewitt J.E., Lyle R., Clark L.N., et al. Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy. Hum Mol Genet. 3:1994;1287-1295.
6. van Deutekom J.C.T., Wijmenga C., Van Tienhoven E.A.E., et al. FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated units. Hum Mol Genet. 2:1993;2037-2042.
7. Lunt P.V., Jardine P.E., Koch M.C., et al. Correlation between fragment size at D4F104S1 and age at onset or at wheelchair use, with a possible generational effect, accounts for much phenotypic variation in 4q35-facioscapulohumeral muscular dystrophy (FSHD). Hum Mol Genet. 4:1995;951-958.
8. Tawil R., Forrester J., Griggs R.C., et al. Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. Ann Neurol. 39:1996;744-748.
9. Ricci E., Galluzzi G., Deidda G., et al. Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype. Ann Neurol. (45):1999;751-757.
10. Padberg G.W., Brouwer O.F., de Keizer R.J.W., et al. On the significance of retinal vascular disease and hearing loss in facioscapulohumeral muscular dystrophy. Muscle Nerve. (Suppl 2):1995;S73-S80.
11. Fitzsimons R.B., Gurwin E.B., Bird A.C. Retinal vascular abnormalities in facioscapulohumeral muscular dystrophy. Brain. 110:1987;631-648.
12. Laforet P., de Toma C., Eymard B., et al. Cardiac involvement in genetically confirmed facioscapulohumeral muscular dystrophy. Neurology. 51:(5):1998;1454-1456.
13. Brouwer O.F., Padberg G.W., Bakker E., Wijmenga C., Frants R.R. Early onset facioscapulohumeral muscular dystrophy. Muscle Nerve. (Suppl 2):1995;S67-S72.
14. Funakoshi M., Goto K., Arahata K. Epilepsy and mental retardation in a subset of early onset 4q35-facioscapulohumeral muscular dystrophy. Neurology. 50:1998;1791-1794.
15. Hallett M. Transcranial magnetic stimulation and the human brain. Nature. 406:2000;147-150.
16. Di Lazzaro V., Restuccia D., Servidei S., et al. Functional involvement of central nervous system in mitochondrial disorders. Electroencephalogr Clin Neurophysiol. 105:1997;171-180.
17. Di Lazzaro V., Restuccia D., Servidei S., et al. Functional involvement of cerebral cortex in Duchenne muscular dystrophy. Muscle Nerve. 21:1998;662-664.
18. Brown P., Ridding M.C., Werhahn K.J., Rothwell J.C., Marsden C.D. Abnormalities of the balance between inhibition and excitation in the motor cortex of patients with cortical myoclonus. Brain. 119:1996;309-317.
19. Caramia M.D., Gigli G., Iani C., et al. Distinguishing forms of generalized epilepsy using magnetic brain stimulation. Electroencephalogr Clin Neurophysiol. 98:1996;14-19.
20. Ziemann U., Steinhoff B.J., Tergau F., Paulus W. Transcranial magnetic stimulation: its current role in epilepsy research. Epilepsy Res. 30:1998;11-30.
21. Cantello R., Civardi C., Cavalli A., et al. Cortical excitability in cryptogenic localization-related epilepsy: interictal transcranial magnetic stimulation studies. Epilepsia. 41:2000;694-704.
22. Manganotti P., Tamburin S., Zanette G., Fiaschi A. Hyperexcitable cortical responses in progressive myoclonic epilepsy: a TMS study. Neurology. 57:2001;1793-1799.
23. Cacurri S., Deidda G., Piazzo N., et al. Chromosome 4q35 haplotypes and DNA rearrangements segregating in affected subjects of 19 Italian families with facioscapulohumeral muscular dystrophy (FSHD). Hum Genet. 94:1994;367-374.
24. Deidda G., Cacurri S., Piazzo N., Felicetti L. Direct detection of 4q35 rearrangements implicated in facioscapulohumeral muscular dystrophy. J Med Genet. 33:1996;361-365.
25. Cacurri S., Piazzo N., Deidda G., et al. Sequence homology between 4qter and 10qter loci facilitates the instability of subtelomeric KpnI repeat units implicated in facioscapulohumeral muscular dystrophy. Am J Hum Genet. 63:1998;181-190.
26. Wechsler D. Manuale della Scala d'Intelligenza Wechsler per Adulti. Adattamento Italiano a cura di F.G. Ferradini ed A. Vassena. O.S. Organizzazioni Speciali Firenze; 1974.
27. Sanger T.D., Garg R.R., Chen R. Interaction between two different inhibitory systems in the human motor cortex. J Physiol. 530:2001;307-317.
28. Ziemann U., Lonnecker S., Steinhof B.J., Paulus W. The effect of lorazepam on the motor cortical excitability in man. Exp Brain Res. 109:1996;127-135.
29. Ziemann U., Lonnecker S., Steinhoff B.J., Paulus W. Effects of antiepileptics drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann Neurol. 40:1996;367-378.
30. Di Lazzaro V., Oliviero A., Meglio M., et al. Direct demonstration of the effect of lorazepam on the excitability of the human motor cortex. Clin Neurophysiol. 111:2000;794-799.
31. Kujirai T., Caramia M.D., Rothwell J.C., et al. Corticocortical inhibition in human motor cortex. J Physiol (London). 471:1993;501-519.
32. Di Lazzaro V., Restuccia D., Oliviero A., et al. Magnetic transcranial stimulation at intensities below active motor threshold activates intracortical inhibitory circuits. Exp Brain Res. 119:1998;265-268.
33. Guidotti A., Toffano G., Costa E. An endogenous protein modulates the affinity of GABA and benzodiazepine receptors in rat brain. Nature. 257:(3):1978;553-555.
34. Guidotti A., Forchetti C.M., Corda M.G., Konkel D., Bennett C.D., Costa E. Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. Proc Natl Acad Sci USA. 80:1983;3531-3535.
35. Haslett J.N., Sanoudou D., Kho A.T., et al. Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle. Proc Natl Acad Sci USA. 99:2002;15000-15005.
36. Chen Y.W., Zhao P., Borup R., Hoffman E.P. Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology. J Cell Biol. 151:(6):2000;1321-1336.
37. Campanaro S., Romualdi C., Fanin M., et al. Gene expression profiling in dysferlinopathies using a dedicated muscle microarray. Hum Mol Genet. 11:2002;3283-3298.
38. Mochizuki H., Hanajima R., Kowa H., et al. Somatosensory evoked potential recovery in myotonic dystrophy. Clin Neurophysiol. 112:2001;793-799.
39. Ziemann U., Muellbacher W., Hallett M., Cohen L.G. Modulation of practice-dependent plasticity in human motor cortex. Brain. 124:2001;1171-1181.
40. Di Lazzaro V., Oliviero A., Profice P., et al. Ketamine increases motor cortex excitability to transcranial magnetic stimulation. J Physiol. January 17:2003;. 10.1113/jphysiol.2002.030486.
41. Di Lazzaro V., Oliviero A., Profice P., et al. Comparison of descending volleys evoked by transcranial magnetic and electric stimulation in conscious humans. Electroencephalogr Clin Neurophysiol. 109:1998;397-401.
42. Di Lazzaro V., Restuccia D., Oliviero A., et al. Effects of voluntary contraction on descending volleys evoked by transcranial stimulation in conscious humans. J Physiol. 508:1998;625-633.
43. Donoghue J.P., Suner S., Sanes J.N. Dynamic organization of primary motor cortex output to target muscles in adult rats. II. Rapid reorganization following motor nerve lesions. Exp Brain Res. 79:1990;492-503.
44. D'Angelo M.G., Bresolin N. Report of the 95th European Neuromuscular Centre (ENMC) sponsored International Workshop Cognitive Impairment in Neuromuscular Disorders, Naarden, The Netherlands, 13-15 July 2001. Neuromuscul Disord. 13:2003;72-79.